Neisserial vaccine compositions comprising a combination of antigens

Details for Australian Patent Application No. 2008202479 (hide)

Owner GlaxoSmithKline Biologicals s.a

Inventors Weynants, Vincent; Berthet, FrancoisXavier Jacques; Biemans, Ralph; Poolman, Jan; Feron, Christiane; Goraj, Carine; Denoel, Philippe

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008202479

Parent 2003250204

Filing date 4 June 2008

Wipo publication date 26 June 2008

Acceptance publication date 22 September 2011

International Classifications

C07K 14/22 (2006.01) Peptides having more than 20 amino acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/095 (2006.01) Medicinal preparations containing antigens or antibodies - Neisseria

A61K 39/102 (2006.01) Medicinal preparations containing antigens or antibodies - Pasteurella

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

Event Publications

19 June 2008 Complete Application Filed

26 June 2008 Application Open to Public Inspection

  Published as AU-B-2008202479

22 September 2011 Application Accepted

  Published as AU-B-2008202479

19 January 2012 Opposition Lodged

  Novartis Vaccines & Diagnostics, Inc has lodged an opposition against GlaxoSmithKline Biologicals s.a.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008202480-Synthetic derivatives of 21-butenyl and related spinosyns

2008202478-An undercarriage fitted with a communication device between a wheel and the undercarriage